For example, it is unnecessary to call “CD44(+)/CD24(-) and ALDH1(+)” breast cancer cells as CSC 843-846, since “CD44(+)/CD24(-) and ALDH1(+)” defines them more specifically and clearly than the equivocal “CSC”. This evidence concerns the gene CD44 and breast carcinoma.